Literature DB >> 10356065

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.

P Krack1, P Pollak, P Limousin, A Benazzouz, G Deuschl, A L Benabid.   

Abstract

The effect of chronic bilateral high-frequency stimulation of the subthalamic nucleus (STN) on levodopa-induced dyskinaesias was investigated in eight patients with fluctuating Parkinson's disease complicated by functionally disabling off-period dystonia. All of the patients also had severe diphasic and peak-dose chorea, so that it was possible to study the effect of high-frequency stimulation on the different types of levodopa-induced dyskinaesias. Off-period fixed dystonia was reduced by 90% and off-period pain by 66%. After acute levodopa challenge, high-frequency stimulation of the STN reduced diphasic mobile dystonia by 50% and peak-dose choreic dyskinaesias by 30%. The effect of bilateral high-frequency stimulation of the STN on the Unified Parkinson's Disease Rating Scale motor score had the same magnitude as the preoperative effect of levodopa. This allowed the levodopa dose to be reduced by 47%. The combination of reduced medication and continuous high-frequency stimulation of the STN reduced the duration of on-period diphasic and peak-dose dyskinaesias by 52% and the intensity by 68%. Acute high-frequency stimulation of the STN mimics an acute levodopa challenge, concerning both parkinsonism and dyskinaesias, and suppresses off-period dystonia. Increasing the voltage can induce repetitive dystonic dyskinaesias, mimicking diphasic levodopa-induced dyskinaesias. A further increase in voltage leads to a shift from a diphasic-pattern dystonia to a peak-dose pattern choreodystonia. Chronic high-frequency stimulation of the STN also mimics the benefit of levodopa on parkinsonism and improves all kinds of levodopa-induced dyskinaesias to varying degrees. Off-period dystonia, associated with neuronal hyperactivity in the STN is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinaesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Chronic high-frequency stimulation of the STN allows a very gradual increase in stimulation parameters with increasing beneficial effect on parkinsonism while reducing the threshold for the elicitation of stimulation-induced dyskinaesias. In parallel with improvement of parkinsonism, the levodopa dose can be gradually decreased. As diphasic dystonic dyskinaesias are improved to a greater degree than peak-dose dyskinaesias, both direct and indirect mechanisms may be involved. Peak-dose choreatic dyskinaesias, associated with little evidence of parkinsonism and thus with low neuronal activity in the STN, are improved, mostly indirectly. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum reflecting a continuous spectrum of underlying activity patterns of STN neurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356065     DOI: 10.1093/brain/122.6.1133

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  33 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Two-year outcomes of deep brain stimulation in adults with cerebral palsy.

Authors:  Ae Ryoung Kim; Jin Woo Chang; Won Seok Chang; Eun Sook Park; Sung-Rae Cho
Journal:  Ann Rehabil Med       Date:  2014-04-29

Review 4.  Deep brain stimulation for Parkinson's disease.

Authors:  Patricia Limousin; Irene Martinez-Torres
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  Subthalamic nucleus stimulation in Parkinson's disease is associated with a risk of fixed epiglottis.

Authors:  H Kataoka; Maya Yanase; Makoto Kawahara; Hidehiro Hirabayashi; Toshiaki Yamanaka; Makito Hirano; Satoshi Ueno
Journal:  BMJ Case Rep       Date:  2009-02-02

6.  DBS candidates that fall short on a levodopa challenge test: alternative and important indications.

Authors:  Takashi Morishita; Maryam Rahman; Kelly D Foote; Kyle M Fargen; Charles E Jacobson; Hubert H Fernandez; Ramon L Rodriguez; Irene A Malaty; Dawn Bowers; Christopher J Hass; Yoichi Katayama; Takamitsu Yamamoto; Michael S Okun
Journal:  Neurologist       Date:  2011-09       Impact factor: 1.398

Review 7.  Motor Complications of Dopaminergic Medications in Parkinson's Disease.

Authors:  Maria Eliza Freitas; Christopher W Hess; Susan H Fox
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

8.  Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease.

Authors:  T J Loher; J-M Burgunder; S Weber; R Sommerhalder; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 9.  Levodopa-induced dyskinesias and their management.

Authors:  Francesca Del Sorbo; Alberto Albanese
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

10.  Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease.

Authors:  T Hershey; J Wu; P M Weaver; D C Perantie; M Karimi; S D Tabbal; J S Perlmutter
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.